TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study

Simple Summary The status of microsatellite instability (MSI-H) in gastric or gastroesophageal junction cancer (GC/GEJC) patients eligible for radical surgery proved to be prognostic for an improved survival outcome and predictive for poor/no benefit from the combination of adjuvant/peri-operative c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-06, Vol.13 (11), p.2839, Article 2839
Hauptverfasser:	Raimondi, Alessandra, Palermo, Federica, Prisciandaro, Michele, Aglietta, Massimo, Antonuzzo, Lorenzo, Aprile, Giuseppe, Berardi, Rossana, Cardellino, Giovanni G., De Manzoni, Giovanni, De Vita, Ferdinando, Di Maio, Massimo, Fornaro, Lorenzo, Frassineti, Giovanni L., Granetto, Cristina, Iachetta, Francesco, Lonardi, Sara, Murialdo, Roberto, Ongaro, Elena, Pucci, Francesca, Ratti, Margherita, Silvestris, Nicola, Smiroldo, Valeria, Spallanzani, Andrea, Strippoli, Antonia, Tamberi, Stefano, Tamburini, Emiliano, Zaniboni, Alberto, Di Bartolomeo, Maria, Cremolini, Chiara, Sposito, Carlo, Mazzaferro, Vincenzo, Pietrantonio, Filippo
Format:	Artikel
Sprache:	eng
Schlagworte:	Biopsy Cancer Cancer therapies Chemotherapy Clinical trials Disease Enrollments Gastrectomy Gastrointestinal surgery Hepatitis Hypotheses Immune checkpoint inhibitors Immunotherapy Life Sciences & Biomedicine Metastasis Microsatellite instability Oncology Patients Science & Technology Study Protocol Surgery Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!